Literature DB >> 31602964

Fully integrated [18F]FDG PET/MR in large vessel vasculitis.

Roberto Padoan1, Filippo Crimì2, Mara Felicetti3, Federica Padovano4, Carmelo Lacognata2, Roberto Stramare2, Emilio Quaia2, Diego Cecchin4,5, Franco Bui4, Pietro Zucchetta4, Franco Schiavon3.   

Abstract

BACKGROUND: The aim of this study is to evaluate the usefulness of [18F] fluorodeoxyglucose (FDG) positron emission tomography (PET)/magnetic resonance (MR) in large vessels vasculitis (LVV) patients.
METHODS: We performed an observational retrospective study based on our records. Images were acquired on a PET/MR scanner using [18F]FDG-PET whole body imaging. For each PET scan, a qualitative analysis and a semi-quantitative measure using the maximum of the standardized uptake value (SUV<inf>max</inf>) were performed. SUV<inf>max</inf> measurements normalized to the liver uptake were categorized using a grading scale. Vessel's wall thickness (WT) was measured at five fixed points (inferior margin of T5, T9, T12, L3, thickest area [max WT]).
RESULTS: Twenty-three LVV patients were included, 56.5% giant cells arteritis, 34.8% Takayasu's arteritis and 8.7% isolated aortitis, all Caucasian, mostly females (82%). We considered 32 PET scans for the LVV group (from a minimum of one to a maximum of three scans per patient) mainly during follow-up (29/32 scans), and 23 PET scans from a control group of non-metastatic malignancies patients. We found higher SUV<inf>max</inf> compared to controls, in all sites, irrespective of clinical disease activity. Mean WT resulted higher in patients than in controls but was not correlated to SUV<inf>max</inf>. Mean WT positively correlated with age in both cohorts, inversely correlated to disease duration, while no correlation with SUV<inf>max</inf> was observed. The concordance between clinically active disease and PET hypermetabolism was poor (Cohen' κ=0.33).
CONCLUSIONS: PET/MR is a safe imaging technique capable of detecting inflammation in aortic wall. Low radiological exposure of PET/MR should be considered especially in young women receiving follow-up studies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31602964     DOI: 10.23736/S1824-4785.19.03184-4

Source DB:  PubMed          Journal:  Q J Nucl Med Mol Imaging        ISSN: 1824-4785            Impact factor:   1.560


  3 in total

1.  Does [18F]F-FDG-PET/MRI add metabolic information to magnetic resonance image in childhood-onset Takayasu's arteritis patients? A multicenter case series.

Authors:  Gleice Clemente; Alexandre W de Souza; Hilton Leão Filho; Fernando M A Coelho; Carlos Buchpiguel; Marcos Lima; Camila Carneiro; Rosa M R Pereira; Nadia Aikawa; Clovis A Silva; Lucia M A Campos; Gabriel Alves; Camilla Astley; Bruno Gualano; Maria Teresa Terreri
Journal:  Adv Rheumatol       Date:  2022-07-25

Review 2.  Role of Cardiovascular Magnetic Resonance to Assess Cardiovascular Inflammation.

Authors:  Domenico Filomena; Tom Dresselaers; Jan Bogaert
Journal:  Front Cardiovasc Med       Date:  2022-07-06

Review 3.  Looking ahead: giant-cell arteritis in 10 years time.

Authors:  Milena Bond; Alessandro Tomelleri; Frank Buttgereit; Eric L Matteson; Christian Dejaco
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-24       Impact factor: 3.625

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.